MedMen Enterprises (MMNFF) Stock Price, News & Analysis

Company Overview

MedMen Enterprises is a vertically integrated cannabis company that cultivates, manufactures, and sells a diverse range of cannabis products primarily in the United States. The company operates through a network of retail dispensaries, cultivation facilities, and processing centers, offering customers flower, pre-rolls, oils, edibles, tinctures, and topicals. MedMen’s retail locations are designed to deliver a customer-focused experience, with knowledgeable staff providing guidance on product selection and responsible consumption.

In its cultivation and production segment, MedMen employs modern greenhouse and indoor growing techniques to maintain consistent quality and potency across its product lines. The company’s manufacturing operations include extraction and formulation labs, where it develops proprietary concentrates, vape cartridges, and infused products under in-house brands. Complementing its core offerings, MedMen provides ancillary accessories such as vaporizers and branded merchandise to round out its retail portfolio.

Founded in 2010 by Adam Bierman and Andrew Modlin, MedMen has expanded through organic growth and strategic acquisitions, including the purchase of cultivation assets and regional dispensary chains. This growth strategy has helped the company establish a footprint in key cannabis markets such as California, Nevada, Arizona, Florida, and Massachusetts. MedMen also maintains a licensing arm that seeks to secure additional retail and cultivation opportunities as new state markets legalize cannabis.

Under the leadership of a seasoned management team—headed by CEO Tom Lynch—MedMen continues to refine its operations and pursue further expansion. The company’s governance framework includes a board of directors with expertise in consumer retail, pharmaceuticals, and regulatory compliance. MedMen’s ongoing efforts focus on optimizing its supply chain, enhancing customer experiences, and delivering consistent, high-quality products in a rapidly evolving industry landscape.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 6,100 shs
• Average Volume: 705,413 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

MMNFF Stock Analysis - Frequently Asked Questions

How were MedMen Enterprises' earnings last quarter?

MedMen Enterprises Inc. (OTCMKTS:MMNFF) released its earnings results on Monday, February, 15th. The company reported ($0.11) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.08) by $0.03.

How do I buy shares of MedMen Enterprises?

Shares of MMNFF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 2/15/2021
• Today: 7/14/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:MMNFF
• CIK: 1776932
• Web: www.medmen.com
• Phone: (855) 292-8399
• Fax: N/A
• Employees: 428
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A